Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-25-228343

Co-Chief Executive Officer sold 29,975 shares at an average $14.38 ($430,952)

From the SEC's structured data for this filing

Trades in this filing

Klee Justin B. · Co-Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-30 Sale : show line 1 in the form −29,775 $14.37 $427,950 3,325,501 D
2025-09-30 Sale : show line 2 in the form −200 $15.01 $3,002 3,325,301 D
Open-market sales · 29,975 sh · avg $14.38 · $430,952
Loading xslF345X05/ownership.xml…